TAO Synergies Inc. (TAOX) Stock Ticker
Market factors today
Unlock the full TAOX picture
About TAO Synergies Inc.
TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on the management of digital assets, primarily focusing on the acquisition and 'staking' of TAO cryptocurrency.
TAOX stock facts
| Ticker symbol | TAOX |
| Exchange | NASDAQ Global Market |
| Sector | Technology |
| Industry | Software - Application |
| Market cap | $33.1M |
| CEO | Joshua N. Silverman |
| Employees | 5 |
| Headquarters | New York, NY, US |
| IPO date | 2025-07-02 |
| Website | www.taosynergies.com |
What you can see for TAOX on Tickr
Live TAOX price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the TAOX report.
Rankings
FAQ
What is the ticker symbol for TAO Synergies Inc.?
The ticker symbol for TAO Synergies Inc. is TAOX, listed on the NASDAQ Global Market.
What is TAOX?
TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on…